Scarica l'app Stockscreener
57.43
0.16%
-0.09
Dopo l'orario di chiusura:
57.40
-0.03
-0.05%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TGTX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$57.52
Aprire:
$57.97
Volume 24 ore:
1.27M
Relative Volume:
0.59
Capitalizzazione di mercato:
$8.79B
Reddito:
$700.35M
Utile/perdita netta:
$461.90M
Rapporto P/E:
20.01
EPS:
2.8696
Flusso di cassa netto:
$-14.19M
1 W Prestazione:
+0.98%
1M Prestazione:
+3.63%
6M Prestazione:
+80.48%
1 anno Prestazione:
+65.79%
Intervallo 1D:
$56.61
$58.69
Intervallo di 1 settimana:
$54.78
$58.92
Portata 52W:
$26.76
$59.30
Tg Therapeutics Inc Stock (TGTX) Company Profile
Nome
Tg Therapeutics Inc
Settore
Industria
Telefono
(212) 554-4484
Indirizzo
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Compare TGTX vs VRTX, REGN, MRNA, ARGX, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TGTX
Tg Therapeutics Inc
|
57.43 | 8.79B | 700.35M | 461.90M | -14.19M | 2.8696 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-06 | Ripresa | H.C. Wainwright | Buy |
| 2025-07-10 | Ripresa | Goldman | Neutral |
| 2024-10-29 | Iniziato | TD Cowen | Buy |
| 2023-08-02 | Aggiornamento | Goldman | Sell → Neutral |
| 2023-06-26 | Ripresa | Jefferies | Buy |
| 2022-05-20 | Iniziato | BofA Securities | Underperform |
| 2022-02-23 | Reiterato | B. Riley Securities | Buy |
| 2021-11-15 | Downgrade | Goldman | Neutral → Sell |
| 2021-04-20 | Iniziato | Goldman | Neutral |
| 2021-04-19 | Reiterato | H.C. Wainwright | Buy |
| 2020-09-01 | Iniziato | JP Morgan | Overweight |
| 2020-08-11 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-05 | Iniziato | Evercore ISI | Outperform |
| 2020-01-17 | Reiterato | H.C. Wainwright | Buy |
| 2019-11-27 | Ripresa | B. Riley FBR | Buy |
| 2019-02-06 | Ripresa | Jefferies | Buy |
| 2018-09-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2018-03-09 | Reiterato | B. Riley FBR, Inc. | Buy |
| 2017-12-01 | Ripresa | B. Riley FBR, Inc. | Buy |
| 2017-11-14 | Ripresa | H.C. Wainwright | Buy |
| 2017-04-25 | Iniziato | Jefferies | Buy |
| 2017-03-06 | Reiterato | FBR & Co. | Outperform |
| 2016-10-06 | Ripresa | Brean Capital | Buy |
| 2016-05-27 | Iniziato | SunTrust | Buy |
| 2015-12-01 | Iniziato | FBR Capital | Outperform |
| 2015-09-09 | Iniziato | Raymond James | Strong Buy |
| 2015-08-12 | Ripresa | H.C. Wainwright | Buy |
| 2015-06-19 | Reiterato | Brean Capital | Buy |
| 2014-12-11 | Reiterato | ROTH Capital | Buy |
| 2014-12-10 | Reiterato | ROTH Capital | Buy |
Mostra tutto
Tg Therapeutics Inc Borsa (TGTX) Ultime notizie
TG Therapeutics, Inc. (TGTX) Options ChainYahoo Finance - ca.finance.yahoo.com
Top Generate Biomedicines (GENB) Competitors 2026 - MarketBeat
TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo Finance UK
TG Therapeutics, Inc. (TGTX) Stock Forecasts - finance.yahoo.com
TG Therapeutics, Inc. (TGTX) Stock Price, News, Quote & History - Yahoo! Finance Canada
TG Therapeutics Inc (TGTX) Stock Price Today: $56.12 - Pluang
(TGTX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
TG Therapeutics, Inc. (TGTX) Latest Stock News & Headlines - Yahoo Finance
TG Therapeutics (NASDAQ:TGTX) Combines Strong Growth With a Tight Technical Breakout Setup - ChartMill
TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 22.59% Upside Potential in the Biotech Sector - DirectorsTalk Interviews
TGTX Stock Rises On Wall Street Price Target Hike, New Schizophrenia Trial Launch - Stocktwits
TG Therapeutics Inc (TGTX) Stock Price, Quote, News & History - Benzinga
TGTX 2-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages TG Therapeutics (TGTX) Investors with Losses to Contact Firm's Attorneys Before Sept. 16th Deadline in Securities Fraud Class Action - TMX Newsfile
TG Therapeutics Eyes $1B Run Rate as BRIUMVI Gains MS Market Share - TradingView
TG Therapeutics (TGTX) Could Be 19% Undervalued After Its Recent Rebound - Yahoo Finance
TG Therapeutics (TGTX) Stock May Be Undervalued On Its Earnings Story - simplywall.st
Insider Decision: Laurence N Charney Offloads $274K Worth Of TG Therapeutics Stock - Benzinga
Tax-related share sale by TG Therapeutics (TGTX) director - stocktitan.net
TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Gem With A 29% Upside Potential - DirectorsTalk Interviews
TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - 富途牛牛
TGTX Stock Continues Rally For 8 Straight Sessions On New BRIUMVI Clinical Data - Stocktwits
TGTX Stock On Track For Best Day In 3.5 Months Amid Fresh Buyout Rumors - Stocktwits
Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st
TG Therapeutics (NASDAQ: TGTX) director plans $274,794.08 stock sale - Stock Titan
TG Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference - Quiver Quantitative
TG Therapeutics at Cantor conference: briumvi gains momentum By Investing.com - Investing.com Canada
TGTX: BRIUMVI targets $1B+ run rate, expanding with subQ and simplified dosing, backed by strong IP - TradingView
TG Therapeutics (TGTX) to Report Q2 Results: Wall Street Expects Earnings Growth - Eastern Progress
TG Therapeutics, Inc. (TGTX) Stock Analysis: Unveiling a 24.52% Upside Potential in the Biotech Sector - DirectorsTalk Interviews
TG Therapeutics to Participate in the Cantor Global Healthcare Conference - manilatimes.net
B. Riley Securities Remains a Buy on TG Therapeutics (TGTX) - The Globe and Mail
(TGTX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
IBD Stock Of The Day, TG Therapeutics, Eyes Breakout After Topping Early Buy Point - Investor's Business Daily
TG Therapeutics (TGTX) Up 15.1% Since Last Earnings Report: Can It Continue? - finance.yahoo.com
B. Riley Securities Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $86 - Moomoo
TGTX Reiterated by HC Wainwright & Co. -- Price Target Maintained at $78 - GuruFocus
H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $78 - Moomoo
TG Therapeutics, Inc. (TGTX) Stock Analysis: Strong Revenue Growth and Promising Potential Upside for Investors - DirectorsTalk Interviews
Price to book forward of TG Therapeutics, Inc. – NASDAQ:TGTX - TradingView
TG Therapeutics: Briumvi's Peak May Be Far Away (Rating Upgrade) (NASDAQ:TGTX) - Seeking Alpha
TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 28% Potential Upside with Innovative Biotech Solutions - DirectorsTalk Interviews
TGTX Rallies As TG Therapeutics Hikes 2026 Revenue Outlook - timothysykes.com
TG Therapeutics (TGTX) Stock Still Looks Cheap Even After Strong Returns - Sahm
TG Therapeutics: Briumvi's Growth Attracts Buyout Rumors (NASDAQ:TGTX) - Seeking Alpha
TGTX Stock Alert: What to Know as Takeover Rumors Swirl Around TG Therapeutics - Yahoo Finance
TG Therapeutics Stock Jumps as Investors Reassess Growth Outlook - Quiver Quantitative
Tg Therapeutics Inc Azioni (TGTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.06%
2.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):